Siren LLC’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.52M Hold
368,598
0.29% 61
2025
Q1
$5.95M Sell
368,598
-5,402
-1% -$87.2K 0.34% 52
2024
Q4
$8.71M Buy
+374,000
New +$8.71M 0.38% 51